In Vitro Synergy of Biochanin A and Ciprofloxacin against Clinical Isolates of Staphylococcus aureus
- PMID: 25134769
- PMCID: PMC6264242
- DOI: 10.3390/molecules16086656
In Vitro Synergy of Biochanin A and Ciprofloxacin against Clinical Isolates of Staphylococcus aureus
Abstract
Many clinical isolates of Staphylococcus aureus (S. aureus) are resistant to numerous antimicrobials, including the fluoroquinolones (FQs). Flavonoids such as biochanin A (BCA) are compounds that are naturally present in fruits, vegetables, and plant-derived beverages. The goal of this investigation was to study the possible synergy between the antimicrobial agents BCA and ciprofloxacin (CPFX) when used in combination; CPFX was chosen as a representative FQ compound. We used S. aureus strain ATCC 25923 and 11 fluoroquinolone (FQ)-resistant methicillin-resistant S. aureus (MRSA) strains. Results from the drug susceptibility testing and checkerboard assays show that the minimum inhibitory concentration (MIC) of BCA ranged from 64 µg/mL to 512 µg/mL. When BCA was combined with CPFX, the fractional inhibitory concentration index (FICI) data showed that there was synergy in all 12 of the S. aureus strains tested. No antagonistic activity was observed in any of the strains tested. The results of time-kill tests and agar diffusion tests confirm that there was synergy between BCA and CPFX against S. aureus strains. These results suggest that BCA can be combined with FQs to produce a powerful antimicrobial agent.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
, no drug control; □, CPFX; ▲, BCA; *, CPFX plus BCA.
Similar articles
-
Synergistic activity of 1-(1-naphthylmethyl)-piperazine with ciprofloxacin against clinically resistant Staphylococcus aureus, as determined by different methods.Lett Appl Microbiol. 2011 Apr;52(4):372-8. doi: 10.1111/j.1472-765X.2011.03010.x. Epub 2011 Feb 10. Lett Appl Microbiol. 2011. PMID: 21255056
-
Flavonoids from Sophora moorcroftiana and their synergistic antibacterial effects on MRSA.Phytother Res. 2014 Jul;28(7):1071-6. doi: 10.1002/ptr.5098. Epub 2013 Dec 12. Phytother Res. 2014. PMID: 24338874
-
β-Lapachone activity in synergy with conventional antimicrobials against methicillin resistant Staphylococcus aureus strains.Phytomedicine. 2013 Dec 15;21(1):25-9. doi: 10.1016/j.phymed.2013.08.010. Epub 2013 Sep 12. Phytomedicine. 2013. PMID: 24035227
-
Antibiotic Resistance in the Treatment of Staphylococcus aureus Keratitis: a 20-Year Review.Cornea. 2015 Jun;34(6):698-703. doi: 10.1097/ICO.0000000000000431. Cornea. 2015. PMID: 25811722 Free PMC article. Review.
-
In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).Clin Infect Dis. 2012 Sep;55 Suppl 3:S206-14. doi: 10.1093/cid/cis563. Clin Infect Dis. 2012. PMID: 22903953 Review.
Cited by
-
Sprayable ciprofloxacin-loaded poloxamer hydrogels for wound infection treatment.J Drug Deliv Sci Technol. 2023 Nov;89:105000. doi: 10.1016/j.jddst.2023.105000. Epub 2023 Sep 28. J Drug Deliv Sci Technol. 2023. PMID: 37928051
-
Chemical and Biological Properties of Biochanin A and Its Pharmaceutical Applications.Pharmaceutics. 2023 Mar 30;15(4):1105. doi: 10.3390/pharmaceutics15041105. Pharmaceutics. 2023. PMID: 37111591 Free PMC article. Review.
-
Reduction in Rumen Tetracycline-Insensitive Bacteria during a Grain Challenge Using the Isoflavone Biochanin A.Vet Sci. 2023 Apr 4;10(4):273. doi: 10.3390/vetsci10040273. Vet Sci. 2023. PMID: 37104428 Free PMC article.
-
The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic.Front Public Health. 2022 Dec 21;10:1025633. doi: 10.3389/fpubh.2022.1025633. eCollection 2022. Front Public Health. 2022. PMID: 36620240 Free PMC article. Review.
-
Escaping mechanisms of ESKAPE pathogens from antibiotics and their targeting by natural compounds.Biotechnol Rep (Amst). 2022 Apr 4;34:e00728. doi: 10.1016/j.btre.2022.e00728. eCollection 2022 Jun. Biotechnol Rep (Amst). 2022. PMID: 35686013 Free PMC article.
References
-
- Paulsen I.T., Firth M., Skurray R.A. Resistance to antimicrobial agents other than b-lactams. In: Crossley K.B., Archer G.L., editors. The Staphylococci in Human Disease. Churchill Livingstone; New York, NY, USA: 1997. pp. 175–212.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
